Approach Resources, Inc. (NASDAQ:AREX) represented a move of -3.21 percent or $0.11 per share and closed its previous day trading session at $3.02. 533494 Shares were traded in the last trading session with an Average Volume of 633.32 Million Shares. The stock currently has a Market Capitalization of 279.41 Million.
Approach Resources Inc. is an independent energy company engaged in the exploration, development, exploitation, production and acquisition of unconventional natural gas and oil properties onshore in the United States and Western Canada. The Company focuses its growth efforts primarily on finding and developing natural gas reserves in known tight gas sands and shale areas. The Company currently operates in Texas, New Mexico and Kentucky and has a non-operating interest in Western Canada.
The stock traded between $1.93 and $4.21 over 1-Year time period showing its price to sales ratio of 2.7. Approach Resources, Inc. (NASDAQ:AREX).
Right now, the stock has a 50-Day Simple Moving Average of $0.05 and 200-Day Simple Moving Average of $11. Its Price to Free Cash Flow is 7.83 and Price to Book of 0.48.
Analyst’s recommended the stock as 3 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Approach Resources, Inc. (NASDAQ:AREX) reported its Actual EPS of $-0.08/share. The analysts offering Earnings Estimates for the company were believing that Approach Resources, Inc. could bring EPS of $-0.09/share. The difference between Actual EPS and Estimated EPS was 0.01 Percent. Thus showing an Earnings Surprise of 11.1 Percent.
Amedisys Inc. (NASDAQ:AMED)
In the last trading session, Amedisys Inc. (NASDAQ:AMED) added its value by 2.95% closing at the price of $56.16. The stock currently has market capitalization of 1.94 Billion, with average volume of 388.05 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Amedisys Inc. (NASDAQ:AMED) is showing beta of 0.73. This particular value of beta suggests that Amedisys Inc. (NASDAQ:AMED) has historically moved 73% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Amedisys Inc. (NASDAQ:AMED) is at $1.26.
The stock currently has RSI of 56.96. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Amedisys, Inc. is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients. From home health to hospice to personal care, Amedisys team members provide quality, clinically-distinctive care to patients every year. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based recovery and rehabilitation after an operation or injury, care focused on empowering them to manage a chronic disease, palliative care for those with a terminal illness, or hospice care at the end of life. They work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs.
Amedisys Inc. (NASDAQ:AMED) topped its 52-week high price of $65.91 on 06/23/17 and 52-Week Low Price of $45.18 on 02/09/17. The Stock currently has P/E (price to earnings ttm) of 44.54 and Weekly volatility of 4.84% and monthly volatility of 3.50% respectively.